Rallybio

IPO

Unimagined Therapies. Undreamed Outcomes.

New Haven, United States · Founded 2018 · $182.0M raised

Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$182.0M
Last Round
$145.0M Series BMay 2020
Rounds
2

About

Rallybio is a clinical-stage biotechnology company advancing therapies for patients with severe and rare diseases, focused on complement dysregulation and hematology. The company combines deep drug development expertise with a global network of academic partners to translate scientific breakthroughs into life-changing treatments.

Summary

Rallybio is a Biotech company based in New Haven, United States, founded in 2018. It has raised $182.0M in total across 2 rounds, most recently a $145.0M Series B round in May 2020. Investors include Pivotal bioVenture Partners, F-Prime Capital and Viking Global.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BMay 2020
$145.0M

Sign up to see all 3 rounds

IPO through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Rallybio on Indexed.vc
<a href="https://indexed.vc/companies/rallybio"><img src="https://indexed.vc/api/badge/company/rallybio" alt="Rallybio on Indexed.vc" width="260" height="76" /></a>